[Formosa Pharmaceuticals] Resolution at the 115th Annual General Shareholders' Meeting to Lift Non-Compete Restrictions for Directors (including Independent Directors) (Correction of Fiscal Year)

1. Date of Shareholders' Meeting Resolution: 115/05/25 2. Name and Title of the Director Permitted to Engage in Competitive Activities: Director: Ma Hai-Yi Independent Director: Lo Li-Chu 3. Items Permitted for Competitive Activities: Director: Ma Hai-Yi Permitted Item: Independent Director at Acepodia Inc. (Cayman Islands) Independent Director: Lo Li-Chu Permitted Item: Independent Director at Anbang Biopharma Co., Ltd. 4. Period Permitted for Competitive Activities: During their tenure as directors of the Company 5. Resolution Status (Voting result according to Article 209 of the Company Act): Chairman called for a vote. Voting result: The total voting rights of shareholders present was 85,723,637. Votes in favor were 84,632,526, votes against were 295,624, invalid votes were 0, abstentions and non-votes were 795,487. Votes in favor accounted for 98.72% of the total voting rights present; the proposal was passed as originally planned. 6. Name and Title of the Director for competitive activities belonging to businesses in the Mainland China area: (If not a business in the Mainland China area, please input "Not Applicable"): Not Applicable 7. Name of the company in the Mainland China area and the position held: Not Applicable 8. Address of the business in the Mainland China area: Not Applicable 9. Business items of the business in the Mainland China area: Not Applicable 10. Impact on the company's financial and business operations: Not Applicable 11. Amount and shareholding percentage if the director is investing in the Mainland China area business: Not Applicable 12. Other items to be stated: Not Applicable